Panax ginseng C.A. Meyer’in Etkinliği ve Güvenliliği Üzerine Derleme
Panax ginseng (Panax ginseng, C.A. Meyer) (P. ginseng) yüzyıllar boyunca özellikle Doğu Asya kültürlerinde geleneksel bitkisel ilaç olarak kullanılmaktadır. Yapılan araştırmalar P. ginseng’in öğrenme kabiliyetini geliştirdiğini, antidepresan etkisinin bulunduğunu, nörolojik fonksiyonları düzelttiğini ve kan dolaşımını düzenlediğini göstermektedir. Ayrıca karaciğerin korunması ve iyileşmesi üzerine etkili olduğu, erektil disfonksiyonunu düzelttiği, çeşitli kanser hücre gelişmesini inhibe edebildiği bildirilmektedir. Günümüze kadar P. ginseng’in farmakolojik özellikleri üzerine çok sayıda klinik araştırmalar yapılmış olmasında rağmen, birçok sistematik derleme bu ile ilgili verilerin hala yetersiz olduğunu ve klinik etkinlik için güçlü kanıtların bulunamadığını ortaya koymaktadır. P. ginseng’in uzun süredir kullanılması ve klinik çalışma sonuçları bitkinin ciddi bir güvenlilik kaygısı taşımadığını göstermektedir, ancak hipersensitivite reaksiyonları, mide-bağırsak problemleri ve uykusuzluk yapabileceği, ancak bu belirtiler hafif ve geri dönüşümlü etkilerdir. Klinik araştırmalarda etkileşimlerle ilgili olgu sunumlarının doğruluğu kanıtlanamamasına rağmen ilaç-bitki etkileşmeleri açısında dikkat edilmelidir. Yeterli veri olmadığı için hamilelik ve emzirme döneminde ve pediatrik gruplarda kullanılması önerilmemektedir. Bu derleme kapsamında P.ginseng’in geleneksel kullanımı, farmakokinetiği, farmakolojik etkileri, toksisitesi ve güvenli kullanımı tartışılmıştır.
Panax ginseng C.A. Meyer’in Etkinliği ve Güvenliliği Üzerine Derleme
Panax ginseng (Panax ginseng, C.A.Meyer) (P. ginseng) have been used as traditional herbal medicine for centuries, especially in Eastern Asian cultures. The research shows that P. ginseng develops learning ability, has antidepressant effect, ameliorates neurological functions, and regulates blood circulation. Moreover, it has been reported to be effective on liver protection and healing, to improve erectile dysfunction, to inhibit cell progression in various cancer cells. Despite the fact that numerous clinical studies have been conducted on the pharmacological properties of P. ginseng until today, several systematic reviews have revealed that related data is still inconclusive and strong evidence for clinical efficacy cannot be deduced. Due to the long-standing use of P. ginseng and the outcome of clinical trials, it seems not to have serious safety concerns, however it has been reported that it may couse hypersensitivity reactions, gastrointestiral disordes and insomnia. However, these symptoms are mild and reversible. Despite case reports on interactions can not be verified in clinical trials, drug-herbal interactions should be considered. Since there is not enough data, it is not recommended to use during pregnancy and lactation and in pediatric groups. In this review, the traditional use, the pharmacokinetics and pharmacological effects, toxicity and safety use of P. ginseng has been discussed.
___
- 1. Bensky D, Clavey S, Stöger E, Gamble A: Chinese Herbal Medicine
Materia Medica. 3. Baskı. Eastland Press: Seattle, USA, 2004.
- 2. EMA, European Medicines Agency: Assesment report on Panax
ginseng C.A. Meyer, radix. EMA/HMPC/321232/2012. 2013
March 12. Available from: http://www.ema.europa.eu/docs/en_GB/
document_library/Herbal_-_HMPC_assessment_report/2013/04/
WC500142080.pdf.
- 3. Baytop A: Farmasötik Botanik Ders Kitabı. Dialypetalae: İ.Ü.
Basımevi ve Film Merkezi; İstanbul, Türkiye, 1991, pp. 219.
- 4. Choi K: Botanical characteristics, pharmacological effects and
medicinal components of Korean Panax ginseng C A Meyer, Acta
Pharmacologica Sinica 2008, 29(9):1109-1118.
- 5. Ru W, Wang D, Xu Y, He X, Sun YE, Qian L, Zhou X, Qin Y: Chemical
constituents and bioactivities of Panax ginseng (C.A. Mey.). Drug
Discoveries & Therapeutics 2015, 9(1):23-32.
- 6. Ortaç M: Erektil Disfonksiyon Tedavisinde Fitoterapi. Androloji
Bülteni 2016, 18(64):20-23.
- 7. Park KH, Shin HJ, Song YB, Hyun HC, Cho HJ, Ham HS, Yoo YB,
Ko YC, Jun WT, Park HJ: Possible Role of Ginsenoside Rb1 on
Regulation of Rat Liver Triglycerides. Biological & Pharmaceutical
Bulletin 2002, 25(4):457-460.
- 8. Sezgin C. Kanserde Bitkilerle Tedavide Örnek Uygulamalar. In:
Çekin MD, Altuncan F, Yakut A, Tınmaz MZ (eds). Bitkilerle Tedavi
Sempozyumu. Anka; İstanbul. 2011: pp 73-78.
- 9. Yamada N, Araki H, Yoshimura H: Identification of antidepressant-
like ingredients in ginseng root (Panax ginseng C.A. Meyer) using
a menopausal depressive-like state in female mice: participation
of 5-HT2A receptors. Psychopharmacology 2011, 216(4):589-599.
- 10. Ye R, Kong X, Yang Q, Zhang Y, Han J, Zhao G: Ginsenoside Rd
attenuates redox imbalance and improves stroke outcome after focal
cerebral ischemia in aged mice. Neuropharmacology 2011, 61(4),
815-824.
- 11. Kitts DD, Hu C: Efficacy and safety of ginseng. Public Health Nutrition
2000, 3(4A):473-485.
- 12. Tanker N, Koyuncu M, Coşkun M. Farmasötik Botanik Ders Kitabı.
“Spermatophyta”: Ankara. 1993: pp. 350.
- 13. Seely D, Dugoua J, Perri D, Mills E, Koren G: Safety and Efficacy
of Panax Ginseng During Pregnancy and Lactation. The Canadian
Journal of Clinical Pharmacology 2008, 15(1):87-94.
- 14. Lee SM, Bae B, Park H, Ahn N, Cho B, Cho YL, Kwak YS: Characterization
of Korean Red Ginseng (Panax ginseng Meyer): History,
preparation method, and chemical composition. Journal of Ginseng
Research 2015, 39(4):384-391.
- 15. Wan D, Jiao L, Yang H, Liu S: Structural characterization and immunological
activities of the water-soluble oligosaccharides isolated
from the Panax ginseng roots. Planta 2012, 235(6):1289-1297.
- 16. Liu JH, Lee CS, Leung KM, Yan ZK, Shen BH, Zhao ZZ, Jiang ZH:
Quantification of Two Polyacetylenes in Radix Ginseng and Roots
of Related Panax Species Using a Gas Chromatography-Mass Spectrometric
Method. Journal of Agricultural and Food Chemistry 2007,
55(22):8830-8835.
- 17. Quian ZM, Lu J, Gao QP, Li SP: Rapid method for simultaneous
determination of flavonoid, saponins and polyacetylenes in Folium
Ginseng and Radix Ginseng by pressurized liquid extraction and
high-performance liquid chromatography coupled with diode array
detection and mass spectrometry, Journal of Chromatography. A
2009, 1216(18):3825-3830.
- 18. Washida D, Kitanaka S: Determination of Polyacetylenes and
Ginsenosides in Panax Species Using High Performance Liquid
Chromatography. Chemical & Pharmaceutical Bulletin 2003,
51(11):1314-1317.
- 19. Han BH, Park MH, Han YN, Woo LK: Alkaloidal components of
Panax ginseng. Archives of Pharmacal Research 1986, 9(1):21-23.
- 20. Han YN, Ryu SY, Han BH, Woo LK: Spinacine from Panax ginseng.
Archives of Pharmacal Research 1987, 10(4):258-259.
- 21. Park JD, Kim MW, Yoo SJ, Wee JJ: Chemical studies on the
ether-soluble alkaloidal fraction of Panax ginseng. Isolation of 1-carbobutoxy-
β-carboline and 1-carbomethoxy-β-carboline. Archives of
Pharmacal Research 1987, 10:197-199.
- 22. Park JD, Kim MW, Yoo SJ, Wee JJ: A thiazole and two β-carboline
constitutents from Panax ginseng. Archives of Pharmacal Research
1988, 11(1):52-55.
- 23. Han BH, Park MH, Han YN: Isolation of isomaltol-α-d-glucopyranoside1
and ketopropyl-α-d-glucopyranoside2 from Korean red ginseng.
Archives of Pharmacal Research 1985, 8(4): 257-260.
- 24. Matsuura H, Hirao Y, Yoshida S, Kunihiro K, Fuwa T, Kasai R,
Tanaka O: Study of red ginseng: New glucosides and a note on the
occurence of rnaltol. Chemical & Pharmaceutical Bulletin 1984,
32(11):4674.
- 25. Han BH, Park MH, Woo LK, Woo WS, Han YN: Studies on antioxidant
components of Korean ginseng. Korean Journal of Biochemistry
1979, 12(1): 33-40.
- 26. Han BH, Park MH, Han YN: Studies on the antioxidant components
of Korean ginseng (III). Archives of Pharmacal Research 1981,
4(1):53-58.
- 27. Huh BH, Lee IR, Han BH: Lingans from Korean red ginseng, Archives
of Pharmacal Research 1990, 13(3):278-281.
- 28. Chan P, Peckham JC, Malarkey DE, Kissling GE, Travlos GS: Two-
Year Toxicity and Carcinogenicity Studies of Panax ginseng in Fischer
344 Rats and B6C3F1 Mice. National Institute of Environmental
Health Sciences Research Triangle Park 2011, 39(4):779-788.
- 29. Bacanlı M, Başaran N,Başaran AA: İlaç-bitkisel ilaç kullanımının
toksikolojik sonuçları. Türkiye Klinikleri Journal of Pharmacy
Sciences 2012, 1(2):83-94.
- 30. Ernst E: The risk-benefit profile of commonly used herbal therapies:
Ginkgo, St. John’s Wort, Ginseng, Echinacea, Saw Palmetto and
Kava. Annals of Internal Medicine 2002, 136(1):42-53.
- 31. Izzo AA, Carlo GD, Borreli F, Ernst E: Cardiovascular pharmacotherapy
and herbal medicines: the risk of drug interaction. International
Journal of Cardiology 2005, 98(1):1-14.
- 32. Zhao J, Su C, Yang C, Liu M, Tang L, Su W, Liu Z: Determination
of ginsenosides Rb1, Rb2, and Rb3 in rat plasma by a rapid and
sensitive liquid chromatography tandem mass spectrometry method:
Application in a pharmacokinetic study. Journal of Pharmaceutical
and Biomedical Analysis 2012, 64-65:94-97.
- 33 Sun D, Wang B, Shi M, Zhang YX, Zhou LF, Liu ZR, Wu ZL, Jiang
W, Han JL, Xiong LZ, Zhao G: Pharmacokinetic, tissue distribution
and excretion of ginsenoside-Rd in rodents. Phytomedicine : International
Journal of Phytotherapy and Phytopharmacology 2012,
19(3-4):369-373.
- 34. Xia C, Wang G, Sun J, Hao H, Xiong Y, Gu S, Shang L, Zheng C:
Simultaneous determination of ginsenoside Rg1, Re, Rd, Rb1 and
ophiogonin D in rat plasma by liquid chromatography/electrospray
ionization mass spectrometric method and its application to pharmacokinetic
study of “Shenmai” injection. Journal of Chromatography.
B, Analytical Technologies in the Biomedical and Life Sciences
2008, 862(1-2):72-78.
- 35. Yu K, Ma Y, Shao Q, Qu H, Cheng Y: Simultaneously determination
of five ginsenosides in rabbit plasma using solid-phase extraction and
HPLC/MS technique after intravenous administration of “Shenmai”
injection. Journal of Pharmaceutical and Biomedical Analysis 2007,
44(2):532-539.
- 36. Zhou QL, Zhu DN, Yang YF, Xu W, Yang XW: Simultaneous
quantification of twenty-one ginsenosides and their three aglycones
in rat plasma by a developed UFLC-MS/MS assay: Application to a
pharmacokinetic study of red ginseng. Journal of Pharmaceutical and
Biomedical Analysis 2017, 137:1-12.
- 37. Zhou D, Tong L, Wan M, Wang G, Ye Z, Wang Z, Lin R: An LC-MS
method for simultaneous determination of nine ginsenosides in rat
plasma and its application in pharmacokinetic study. Biomedical
Chromatography : BMC 2011, 25(6):720-726.
- 38. Li L, Chen X, Li D, Zhong D: Identification of 20(S)-Protopanaxadiol
Metabolites in Human Liver Microsomes and Human Hepatocytes.
Drug Metabolism and Pharmacokinetics 2011a, 39(3):472-483.
- 39. Hasegawa H, Sung JH, Matsumiya S, Uchiyama M. Main ginseng
saponin metabolites formed by intestinal bacteria. Planta Medica
1996, 62(5):453-457.
- 40. Tawab MA, Bahr U, Karas M, Wurglics M, Schubert-Zsilavecz M:
Degradation of ginsenosides in humans after oral administration.
Drug Metabolism and Disposition : The Biological Fate of Chemicals
2003, 31(8):1065-1071.
- 41. Kennedy DO, Scholey AB, Drewery L, Marsh VR, Moore B, Ashton
H: Electroencephalograph effects of single doses of Ginkgo biloba
and Panax ginseng in healthy young volunteers. Pharmacology,
Biochemistry, and Behavior 2003, 75(3):701-709.
- 42 Scholey AB, Kennedy DO: Acute, dose-dependent cognitive effects
of Ginkgo biloba, Panax ginseng and their combination in healthy
young volunteers: differential interactions with cognitive demand.
Human Psychopharmacology 2002, 17(1):35-44.
- 43. Hao K, Gong P, Sun SQ, Hao HP, Wang GJ, Dai Y, Liang Y, Xie
L, Li FY. Beneficial estrogen-like effects of ginsenoside Rb1, an
active component of Panax ginseng, on neural 5-HT disposition
and behavioral tasks in ovariectomized mice. European Journal of
Pharmacology 2011, 659(1):15-25.
- 44. Liu L, Hoang-Gia T, Wu H, Lee MR, Gu L, Wang C, Yun BS, Wang
Q, Ye S, Sung CK: Ginsenoside Rb1 improves spatial learning and
memory by regulation of cell genesis in the hippocampal subregions
of rats. Brain Research 2011, 1382:147-154.
- 45. Li Y, Tang J, Khatibi NH, Zhu M, Chen D, Tu L, Chen L, Wang S:
Treatment with Ginsenoside Rb1, A Component of Panax Ginseng
Provides Neuroprotection in Rats Subjected to Subarachnoid Hemorrhage-
Induced Brain Injury. Acta Neurochirurgica. Supplement 2011,
110(Pt2):75-79.
- 46. Wang LCH, Lee TF: Effect of Ginseng Saponins on Cold Tolerance
in Young and Elderly Rats. Planta Medica 2000, 66(2):144-147.
- 47. Etou H, Sakata T, Fujimoto K, Terada K, Yoshimatsu H, Ookuma
K, Hayashi T, Arichi S. [Ginsenoside-Rb1 as a suppressor in central
modulation of feeding in the rat]. Nihon Yakurigaku Zasshi. Folia
Pharmacologica Japonica 1988, 91(1):9-15.
- 48. Li L, Liu J, Yan X, Qin K, Shi M, Lin T, Zhu Y, Kang T, Zhao G:
Protective effects of ginsenoside Rd against okadaic acid-induced
neurotoxicity in vivo and in vitro. Journal of Ethnopharmacology
2011, 138(1):135-141.
- 49. Xu C, Teng J, Chen W, Ge Q, Yang Z, Yu C, Yang Z, Jia W:
20(S)-protopanaxadiol, an active ginseng metabolite, exhibits strong
antidepressant-like effects in animal tests. Progress in Neuro-psychopharmacology
& Biological Psychiatry 2010, 34(8):1402-1411.
- 50. Rhee MY, Kim YS, Bae JH, Na DY, Kim YK, Lee MM, Kim HY:
Effect of Korean Red Ginseng on Arterial Stiffness in Subjects with
Hypertension. The Journal of Alternative and Complementary Medicine
: Research on Paradigm, Practice, and Policy 2011, 17(1):45-49.
- 51. Engels HJ, Fahlman MM, Wirth JC: Effects of ginseng on secretory
IgA, performance, and recovery from interval exercise. Medicine &
Science in Sports & Exercise 2003, 35(4):690-696.
- 52. Wu Y, Xia ZY, Dou J, Zhang L, Xu JJ, Zhao B, Lei S, Liu HM:
Protective effect of ginsenoside Rb1 against myocardial ischemia/
reperfusion injury in streptozotocin-induced diabetic rats. Molecular
Biology Reports 2011, 38(7):4327-4335.
- 53. Wang Z, Li M, Wu WK, Tan HM, Geng DF: Ginsenoside Rb1
Preconditioning Protects Against Myocardial Infarction After
Regional Ischemia and Reperfusion by Activation Phosphatidylinositol-
3-kinase Signal Transduction. Cardiovascular Drugs and
Therapy / Sponsored by the International Society of Cardiovascular
Pharmacotherapy 2008, 22(6):443-452.
- 54. Li J, Xie ZZ, Tang YB, Zhou JG, Guan YY: Ginsenoside-Rd, a purified
component from panax notoginseng saponins, prevents atherosclerosis
in apoE knockout mice. European Journal of Pharmacology
2011, 652(1-3):104-110.
- 55. Deng J, Wang YW, Chen WM, Wu Q, Huang XN: Role of nitric oxide
in ginsenoside rg1-ınduced protection against left ventricular hypertrophy
produced by abdominal aorta coarctation in rats. Biological
and Pharmaceutical Bulletin 2010, 33(4): 631-635.
- 56. Han B, Meng Q, Li Q, Zhang J, Bi Y, Jiang N: Effect of 20(S)-protopanaxatriol
and its epimeric derivatives on myocardial injury induced
by isoproterenol. Arzneimittelforschung 2011, 61(3):148-152.
- 57. Yokozawa T, Kobayashi T, Oura H, Kawashima Y: Studies on the
Mechanism of the Hypoglycemic Activity of Ginsenoside-Rb2 in
Streptozotocin-Diabetic Rats. Chemical & Pharmaceutical Bulletin
1985, 33(2):869-872.
- 58. Cho WCS, Chung WS, Lee SKW, Leung AWN, Cheng CHK, Yue
KKM: Ginsenoside Re of Panax ginseng possesses significant antioxidant
and antihyperlipidemic efficacies in streptozotocin-induced
diabetic rats. European Journal of Pharmacology 2006, 550(1-3):173-
179.
- 59. Liu Z, Wang LJ, Li X, Hu JN, Chen Y, Ruan CC, Sun GZ: Hypoglycemic
Effects of Malonyl-ginsenosides Extracted from the Roots of
Panax ginseng on Streptozotocin-induced Diabetic Mice. Phytotherapy
Research : PTR 2009, 23(10):1426-1430.
- 60. Ma SW, Benzie IF, Chu TT, Fok BS, Tomlinson B, Critchley LA:
Effect of Panax ginseng supplementation on biomarkers of glucose
tolerance, antioxidant status and oxidative stress in type 2 diabetic
subjects: results of a placebo-controlled human intervention trail.
Diabetes, Obesity & Metabolism 2008, 10(11):1125-1127.
- 61. Vuksan V, Sung MK, Sievenpiper JL, Stavro PM, Jenkins AL,
Di Buono M, Lee KS, Leiter LA, Nam KY, Arnason JT, Choi M,
Naeem A: Korean red ginseng ( Panax ginseng) improves glucose
and insulin regulation in well-controlled, type 2 diabetes: results of
a randomized, double-blind, placebo-controlled study of efficacy and
safety. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
2008, 18(1):46-56.
- 62. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra
A: The international index of erectile function (IIEF): a multidimensional
scale for assessment of erectile dysfunction. Urology 1997,
49(6):822-30.
- 63. de Andrade E, de Mesquita AA, Claro Jde A, de Andrade PM, Ortiz V,
Paranhos M, Srougi M. Study of the efficacy of Korean Red Ginseng
in the treatment of erectile dysfunction. Asian Journal of Andrology,
2007, 9(2):241-244.
- 64. Hong B, Ji YH, Hong JH, Nam KY, Ahn TY: A double-blind crossover
study evaluating the efficacy of korean red ginseng in patients
with erectile dysfunction: a preliminary report. Journal of Urology
2002, 168(5):2070-2073.
- 65. Gün Ç, Demirci N: Menopozda bitkisel tedavi kullanımı. Arşiv
Kaynak Tarama Dergisi 2015, 24(4): 520-530.
- 66. Scaglione F, Cogo R, Cocuzza C, Arcidiacono M, Beretta A: Immunomodulatory
effects of Panax ginseng C.A. Meyer (G115) on alveolar
macrophages from patients suffering with chronic bronchitis.
International Journal of Immunotherapy and Cancer Research 1994,
10(1):21-24.
- 67. Saito H, Morita M, Takagi K: Pharmacological studies of Panax Ginseng
Leaves. Japanese Journal of Pharmacology 1973, 23(1):43-56.
(1973).
- 68. Jenny E: On the toxicity of the standardized ginseng extract G115®
and pure ginsenosides. Un published report, 1982.
- 69. Berté F: Toxicological investigation of the standardized ginseng
extract G115®. 1982 (unpublished report).
- 70. National Toxicology Program, 2011. NTP technical report on the
toxicology and carcinogenesis studies of ginseng (CAS NO. 50647-
08-0) in F344/N rats and B6C3F1 mice. İnternet adresi: https://ntp.
niehs.nih.gov/ntp/htdocs/lt_rpts/tr567.pdf (Erişim tarihi: 1/05/2017).
[Website]
- 71. Stevens KR, Cox GE: Effects of feeding Ginseng Extract G115 to
purebred Beagle dogs for 90 days. 1978.
- 72. Timm A: Salmonella typhimurium reverse mutation assay with
Stand. Ginseng Extract G115. Report, CCR Project 149905, 1989.
- 73. Trabucchi E: Teratological investigation of the standardized Ginseng
Extract G115. Investigational Report, 1971.
- 74. Hess FG Jr., Parent RA, Cox GE, Stevens KR, Becci PJ. Reproduction
study in rats of Ginseng Extract G115. Food and Chemical
Toxicology 1982, 20(2):189-192.
- 75. Bressler R: Interactions between ginseng and prescription medications.
Geriatrics 2005, 60(8):16-17.
- 76. Gruenwald J: PDR for Herbal Medicines (Aloe, Echinacea, Flax,
Garlic, Ginkgo, Ginseng, Licorice, Senna, St John’s Wort). Medical
Economics Company; Montvale, New Jersey, USA, 2000. pp 16-8,
261-4, 3135,327-9, 342-4, 346-9, 469-472, 684-7, 719-23.
- 77. Williamson E, Driver S, Baxter K: Stockley’s Herbal Medicines
Interactions (GeneralConsiderations, Aloe vera, Echinacea, Flaxseed,
Garlic, Ginkgo, Ginseng, Liquorice, Senna, St John’s wort, Valerian),
Pharmaceutical Press; Londra, UK, 2009.
- 78. Jones BD, Runikis AM: Interaction of ginseng with phenelzine.
Journal of Clinical Psychopharmacology 1987, 7(3):201-202.
- 79. Brazier NC, Levine MAH: Drug-herb interaction among commonly
used conventional medicines: A compendium for health care professionals.
American Journal of Therapeutics 2003, 10(3):163-169.
- 80. Paik DJ, Lee CH: Review of cases of patient risk associated with
ginseng abuse and misuse. Journal of Ginseng Research 2015,
39(2):89-93.
- 81. Aslan M, Orhan N: Diyabet tedavisinde kullanılan bitkisel ürünler ve
gıda destekleri, Mised 2010, (23-24):27-38.
- 82. Lee JY, Jin HJ, Park JW, Jung SK, Jang JY, Park HS: A Case of
Korean Ginseng-Induced Anaphylaxis Confirmed by Open Oral
Challenge and Basophil Activation Test. Allergy, Asthma & Immunology
Research 2012, 42(2):110-111.
- 83. Lee NH, Son CG: Systematic Review of Randomized Controlled
Trials Evaluating the Efficacy and Safety of Ginseng. Journal of
Acupuncture and Meridian Studies 2011, 4(2):85−97.
- 84. Anderson GD, Rosito G, Mohustsy MA, Elmer GW: Drug interaction
potential of Soy extract and Panax Ginseng. Journal of Clinical Pharmacology
2003, 43(6):643-648.
- 85. Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Cui
Y, Ang CY: Clinical assessment of effects of botanical supplementation
on cytochrome P450 phenotypes in the elderly: St John’s wort,
garlic oil, Panax ginseng and Ginkgo biloba. Drugs Aging 2005,
22(6):525-539.